Children as young as 6 months old are now eligible for omicron Covid vaccines

Children as young as 6 months old are now eligible for omicron Covid vaccines


Luca Moore, 11 months, receives a vaccine against the coronavirus disease (COVID-19) while his mother Dr. Danielle Smith holds him at Northwell Health’s Cohen Children’s Medical Center in New Hyde Park, New York, U.S., June 22, 2022. 

Shannon Stapleton | Reuters

The Centers for Disease Control and Prevention on Friday signed off on omicron vaccines for children as young as 6 months old, giving pharmacies and physicians the green light to start administering the shots.

Children ages 6 months through 5 years old who received the two-dose Moderna primary series can now get an omicron booster two months after their second dose.

Meanwhile, kids ages 6 months through 4 years old who are completing their Pfizer primary series will received the omicron shot as their third dose.

The CDC approval comes a day after the Food and Drug Administration gave its authorization. The CDC’s independent panel of vaccine experts did not meet to discuss the available data before the agency gave the greenlight.

Dr. Peter Marks, head of the FDA’s vaccine division, told parents in a statement Thursday that the agency carefully reviewed the data before authorizing the vaccines for the youngest children.

“Vaccines remain the best defense against the most devastating consequences of disease caused by the currently circulating omicron variant, such as hospitalization and death,” Marks said. “Parents and caregivers can be assured that the FDA has taken a great deal of care in our review.”

CNBC Health & Science

Read CNBC’s latest global health coverage:

Covid infections and hospitalizations are increasing in the U.S. after the Thanksgiving holiday as subvariants that evade immunity more easily have become dominant. During the omicron wave last winter, hospitalizations of children ages 4 and under were five times higher than at the peak of the previous delta wave.

The vast majority of children ages 5 and under have not received a single dose of a Covid vaccine, according to the CDC. Some 95% of children are either unvaccinated or have not completed their primary series of shots, according to the agency.

In a statement Friday, the CDC said it was working with parents to improve confidence in the vaccines. It encouraged parents to talk to their children’s physicians about staying up to date on their shots.

The omicron shots target both the BA.5 subvariant and the original strain of Covid. Data from Pfizer and Moderna indicate that they trigger a better immune response in adults than the old shots do, though smaller independent studies found they weren’t much better.

Scientists generally expect the shots will prevent hospitalizations, but likely won’t do as well in curbing mild illness.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More